BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/20/2023 8:02:58 AM | Browse: 470 | Download: 1443
Publication Name World Journal of Hepatology
Manuscript ID 81125
Country China
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Ablative strategies for recurrent hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Lin Wang, Bao-Xian Liu and Hai-Yi Long
Funding Agency and Grant Number
Corresponding Author Hai-Yi Long, MD, Doctor, Doctor, Department of Medical Ultrasound, Institute of Diagnostic and Interventional Ultrasound, the First Affiliated Hospital of SunYat-sen University, No. 58 Zhongshan Road 2, Guangzhou 510080, Guangdong Province, China. longhy9@mail.sysu.edu.cn
Key Words Hepatocellular carcinoma; Recurrence; Ablative therapy; Thermal ablation
Core Tip Despite the tremendous efforts in the fight against hepatocellular carcinoma, there is still no way to prevent its recurrence. Intrahepatic recurrence can be treated by repeated resection and ablation, and there are many studies showing the advantages and disadvantages of each treatment method. For tumors ≤ 3 cm in diameter, there is no significant difference between surgery resection and radiofrequency/microwave ablation treatment. Non-thermal ablation treatment has clearer borders but a higher postoperative recurrence rate. Percutaneous ethanol injection has comparable efficacy to radiofrequency ablation for small tumors. Multiple recurrences require combined systemic therapy.
Publish Date 2023-04-20 07:26
Citation Wang L, Liu BX, Long HY. Ablative strategies for recurrent hepatocellular carcinoma. World J Hepatol 2023; 15(4): 515-524
URL https://www.wjgnet.com/1948-5182/full/v15/i4/515.htm
DOI https://dx.doi.org/10.4254/wjh.v15.i4.515
Full Article (PDF) WJH-15-515-with-cover.pdf
Full Article (Word) WJH-15-515.docx